Dexmedetomedine Infusion Versus Fentanyl Infusion for Donor Anlgesia During Living Donor Hepatectomy

Sponsor
Mansoura University (Other)
Overall Status
Completed
CT.gov ID
NCT02531529
Collaborator
(none)
70
1
2
14.9
4.7

Study Details

Study Description

Brief Summary

To compare between the analgesic effect of dexmedetomedine infusion versus Fentanyl infusion during donor hepatectomy.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Study Start Date :
Jan 1, 2014
Actual Primary Completion Date :
Mar 1, 2015
Actual Study Completion Date :
Apr 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: D group

intraoperative dexmedetomedine infusion

Drug: dexmedetomedine
intraoperative infusion

Sham Comparator: F group

Intraoperative fentanyl infusion

Drug: Fentanyl

Outcome Measures

Primary Outcome Measures

  1. postoperative VAS scale [3 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • donors of living donor liver transplantation
Exclusion Criteria:
  • patient refusal Known allergy to dexmedetomedine

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mansoura university Mansoura Dkahleya Egypt

Sponsors and Collaborators

  • Mansoura University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
AlRefaey Kandeel, Dr, Mansoura University
ClinicalTrials.gov Identifier:
NCT02531529
Other Study ID Numbers:
  • LTx 1
First Posted:
Aug 24, 2015
Last Update Posted:
Aug 24, 2015
Last Verified:
Aug 1, 2015
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2015